Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Hypospadias
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Prevention

Participation Requirements

Age
Younger than 5 years
Gender
Only males

Description

Participants in this multicenter, double-blind study are randomized to receive trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and intermediate-term results will be published after participants complete 6 months and 5 years of follow-up, respectively.

Participants in this multicenter, double-blind study are randomized to receive trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and intermediate-term results will be published after participants complete 6 months and 5 years of follow-up, respectively.

Tracking Information

NCT #
NCT02096159
Collaborators
The Hospital for Sick Children
Investigators
Principal Investigator: Earl Y Cheng, MD Ann & Robert H Lurie Children's Hospital of Chicago Principal Investigator: Mark A Faasse, MD, MPH Ann & Robert H Lurie Children's Hospital of Chicago